Shopping Cart
- Remove All
- Your shopping cart is currently empty
PI3Kγ Inhibitor 7 (compound 2) is a potent, orally active agent that selectively inhibits PI3Kγ with an IC50 of 3.42 nM and demonstrates antitumor activity [1]. It also exhibits varying inhibitory effects on other PI3K isoforms, with IC50 values of 4768 nM for PI3Kα, 878.1 nM for PI3Kβ, and 355.2 nM for PI3Kδ.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | PI3Kγ Inhibitor 7 (compound 2) is a potent, orally active agent that selectively inhibits PI3Kγ with an IC50 of 3.42 nM and demonstrates antitumor activity [1]. It also exhibits varying inhibitory effects on other PI3K isoforms, with IC50 values of 4768 nM for PI3Kα, 878.1 nM for PI3Kβ, and 355.2 nM for PI3Kδ. |
Targets&IC50 | PI3Kβ:878.1 nM, PI3Kδ:355.2 nM, PI3Kγ:3.42 nM, PI3Kα:4768 nM |
In vivo | PI3Kγ inhibitor 7 (Compound 2) exhibited good pharmacokinetic absorption in ICR mice when administered orally at a dose of 5 mg/kg, with a half-life (t1/2) of 3.4 hours, and a bioavailability (F) of 60% [1]. The same compound, administered once daily at 60 mg/kg orally for a duration of 21 days, demonstrated antitumor activity in mice [1]. |
Molecular Weight | 555.59 |
Formula | C31H25N9O2 |
Cas No. | 2575863-25-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.